{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:43:29Z","timestamp":1774554209703,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijrobp.2019.05.063","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T01:50:40Z","timestamp":1559699440000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost"],"prefix":"10.1016","volume":"105","author":[{"given":"Apar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif J.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Yegya-Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutlay","family":"Sayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuti","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Ohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Eladoumikdachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Toppmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce G.","family":"Haffty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.05.063_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(06)70699-4","article-title":"Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial","volume":"7","author":"Owen","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib4","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/jama.2014.16616","article-title":"Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013","volume":"312","author":"Bekelman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djx068","article-title":"Cost-effectiveness analysis comparing conventional, hypofractionated, and intraoperative radiotherapy for early-stage breast cancer","volume":"109","author":"Deshmukh","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.1997.15.3.963","article-title":"Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France","volume":"15","author":"Romestaing","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib9","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1016\/j.ijrobp.2018.07.1604","article-title":"Utilization and toxicity of breast boost radiation therapy following hypofractionated whole breast irradiation: Comparative analysis of a large, statewide multicenter cohort","volume":"102","author":"Boike","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.breast.2010.03.001","article-title":"Pushing the limits of hypofractionation for adjuvant whole breast radiotherapy","volume":"19","author":"Yarnold","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0360-3016(89)90020-5","article-title":"Response of human tumor cell lines in\u00a0vitro to fractionated irradiation","volume":"16","author":"Matthews","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-8140(87)80151-2","article-title":"The dose-rate effect in human tumour cells","volume":"9","author":"Steel","year":"1987","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0360-3016(94)00423-I","article-title":"Pathophysiology of irradiated skin and breast","volume":"31","author":"Archambeau","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0167-8140(89)90131-X","article-title":"Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 year\u2019s follow-up","volume":"15","author":"Turesson","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1259\/0007-1285-25-300-636","article-title":"Radiotherapy in breast cancer. I. The dose-time relationship theoretical considerations","volume":"25","author":"Cohen","year":"1952","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijrobp.2015.09.011","article-title":"Short-course hypofractionated radiation therapy with boost in women with stages 0 to IIIa breast cancer: a phase 2 trial","volume":"94","author":"Ahlawat","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib19","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/1097-0142(20010615)91:12<2273::AID-CNCR1258>3.0.CO;2-1","article-title":"Form or function? Part 1. Subjective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy","volume":"91","author":"Stanton","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","article-title":"Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer","volume":"94","author":"Whelan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib22","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.2003.02.063","article-title":"Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer","volume":"21","author":"Henderson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib23","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1200\/JCO.2005.10.517","article-title":"Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28","volume":"23","author":"Mamounas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib24","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1200\/JCO.2013.49.7842","article-title":"Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis","volume":"31","author":"Mukesh","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","article-title":"Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy","volume":"82","author":"Donovan","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: A randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2010.04.042","article-title":"Fractionation for whole breast irradiation: An American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"81","author":"Smith","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijrobp.2010.08.027","article-title":"Ductal carcinoma in situ with\u00a0microinvasion: Prognostic implications, long-term outcomes, and\u00a0role of axillary evaluation","volume":"82","author":"Parikh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/cncr.25344","article-title":"Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ","volume":"117","author":"Wai","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2014.07.026","article-title":"Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast","volume":"90","author":"Lalani","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2010.03.021","article-title":"Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ","volume":"95","author":"Williamson","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib32","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.2016.70.7158","article-title":"Hypofractionated postmastectomy radiation therapy is safe and effective: first results from a prospective phase II trial","volume":"35","author":"Khan","year":"2017","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2019.05.063_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ijrobp.2010.11.077","article-title":"Patient preferences and physician practice patterns regarding breast radiotherapy","volume":"82","author":"Hoopes","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10549-017-4120-0","article-title":"Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States","volume":"162","author":"Hasan","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib35","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/93.17.1344","article-title":"Relationship of distance from a radiotherapy facility and initial breast cancer treatment","volume":"93","author":"Nattinger","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib36","series-title":"Talk presented at: San Antonio Breast Cancer Symposium","article-title":"Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK\/06\/003)","author":"Coles","year":"2018"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ijrobp.2018.08.049","article-title":"FAST phase III RCT of radiotherapy hypofractionation for treatment of early breast cancer: 10-year results (CRUKE\/04\/015)","volume":"102","author":"Brunt","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.063_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161930817X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161930817X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:44:42Z","timestamp":1759743882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161930817X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S036030161930817X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.05.063","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}